English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Open

Presents the pdf analysis as premium feature

PDF Analysis

Insights

Presents the summarisation as premium feature

Summarisation

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Background  Comprehensive stroke centers ( CSC s) provide a full spectrum of neurological and neurosurgical services to treat complex stroke patients.  CSC s have been shown to improve clinical outcomes and mitigate disparities in ischemic stroke patients. It is believed that  CSC s also improve outcomes in hemorrhagic stroke.    Methods and Results  We used the Myocardial Infarction Data Acquisition System ( MIDAS ) database, which includes data on patients discharged with a primary diagnosis of intracerebral hemorrhage ( ICH;  International Classification of Diseases, Ninth Revision [ ICD ‐9] 431) and subarachnoid hemorrhage ( SAH; ICD ‐9 430) from all nonfederal acute care hospitals in New Jersey ( NJ ) between 1996 and 2012. Out‐of‐hospital deaths were assessed by matching  MIDAS  records with  NJ  death registration files. The primary outcome variable was 90‐day all‐cause mortality. The primary independent variable was  CSC  versus primary stroke center ( PSC ) and nonstroke center ( NSC ) admission. Multivariate logistic models were used to measure the effects of available covariates. Overall, 36 981 patients were admitted with a primary diagnosis of  ICH  or  SAH  during the study period, of which 40% were admitted to a  CSC . Patients admitted to  CSC s were more likely to have neurosurgical or endovascular interventions than those admitted to a  PSC / NSC  (18.9% vs. 4.7%;  P <0.0001).  CSC  admission was associated with lower adjusted 90‐day mortality (35.0% vs. 40.3%; odds ratio, 0.93; 95% confidence interval, 0.89 to 0.97) for hemorrhagic stroke. This was particularly true for those admitted with  SAH .    Conclusions  Hemorrhagic stroke patients admitted to  CSC s are more likely to receive neurosurgical and endovascular treatments and be alive at 90 days than patients admitted to other hospitals.

Comprehensive Stroke Centers May Be Associated With Improved Survival in Hemorrhagic Stroke